Laboratory Correlates for a Phase II Trial of Romidepsin in Cutaneous and Peripheral T-Cell Lymphoma

British Journal of Haematology - United Kingdom
doi 10.1111/j.1365-2141.2009.07954.x
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Romidepsin: Evidence for Its Potential Use to Manage Previously Treated Cutaneous T Cell Lymphoma

Core Evidence
MedicineReviewsReferencesPharmacology
2010English

A Phase Ii Trial of Brentuximab Vedotin (Bv) and Lenalidomide (Len) in Relapsed and Refractory (R/R) Cutaneous (Ctcl) and Peripheral (Ptcl) T-Cell Lymphomas: Preliminary Results of a Phase Ii Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Phase II Study of Gemcitabine and Bexarotene (GemBex) in the Treatment of Cutaneous T-Cell Lymphoma

2012English

Phase I Study of Romidepsin and Liposomal Doxorubicin in Relapsed or Refractory T-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Nodal Peripheral T-Cell Lymphoma With Secondary Granulomatous Cutaneous Involvement

Acta Dermato-Venereologica
DermatologyMedicine
2004English

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Clinical Case Reports
Medicine
2018English

Phase Ii Fil-Ptcl13 Study of Romidepsin-Choep Followed by High-Dose Chemotherapy and Transplantation in Untreated Peripheral T-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

PRELIMINARY RESULTS OF ASTX660, a NOVEL NON-PEPTIDOMIMETIC cIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T-Cell LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Phase 1 Study of Pralatrexate Plus Romidepsin Reveals Marked Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy